Showing 1 - 2 results of 2 for search 'Leen-Jan van Doorn', query time: 0.01s Refine Results
  1. 1
    Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica.

    Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. by Rolando Herrero, Wim Quint, Allan Hildesheim, Paula Gonzalez, Linda Struijk, Hormuzd A Katki, Carolina Porras, Mark Schiffman, Ana Cecilia Rodriguez, Diane Solomon, Silvia Jimenez, John T Schiller, Douglas R Lowy, Leen-Jan van Doorn, Sholom Wacholder, Aimée R Kreimer, CVT Vaccine Group

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.

    HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays. by Shih-Wen Lin, Arpita Ghosh, Carolina Porras, Sarah C Markt, Ana Cecilia Rodriguez, Mark Schiffman, Sholom Wacholder, Troy J Kemp, Ligia A Pinto, Paula Gonzalez, Nicolas Wentzensen, Mark T Esser, Katie Matys, Ariane Meuree, Wim Quint, Leen-Jan van Doorn, Rolando Herrero, Allan Hildesheim, Mahboobeh Safaeian, Costa Rican Vaccine Trial Group

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: